Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

INTRAGO: intraoperative radiotherapy in glioblastoma multiforme—a phase I/II dose escalation study.

Giordano FA, Brehmer S, Abo-Madyan Y, Welzel G, Sperk E, Keller A, Schneider F, Clausen S, Herskind C, Schmiedek P, Wenz F.

BMC Cancer. 2014 Dec 22;14:992. doi: 10.1186/1471-2407-14-992.

2.

Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: when should they be considered and which questions remain open?

Lohr F, Georg D, Cozzi L, Eich HT, Weber DC, Koeck J, Knäusl B, Dieckmann K, Abo-Madyan Y, Fiandra C, Mueller RP, Engert A, Ricardi U.

Strahlenther Onkol. 2014 Oct;190(10):864-6, 868-71. doi: 10.1007/s00066-014-0719-9. Epub 2014 Sep 11. Review.

PMID:
25209551
3.

Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer.

Abo-Madyan Y, Aziz MH, Aly MM, Schneider F, Sperk E, Clausen S, Giordano FA, Herskind C, Steil V, Wenz F, Glatting G.

Radiother Oncol. 2014 Mar;110(3):471-6. doi: 10.1016/j.radonc.2013.12.002. Epub 2014 Jan 17.

PMID:
24444525
4.

A novel approach for superficial intraoperative radiotherapy (IORT) using a 50 kV X-ray source: a technical and case report.

Schneider F, Clausen S, Thölking J, Wenz F, Abo-Madyan Y.

J Appl Clin Med Phys. 2014 Jan 6;15(1):4502. doi: 10.1120/jacmp.v15i1.4502.

PMID:
24423847
5.

Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity.

Shelan M, Abo-Madyan Y, Welzel G, Bolenz C, Kosakowski J, Behnam N, Wenz F, Lohr F.

Radiat Oncol. 2013 Nov 27;8:276. doi: 10.1186/1748-717X-8-276.

6.

Estimation of intracranial failure risk following hippocampal-sparing whole brain radiotherapy.

Harth S, Abo-Madyan Y, Zheng L, Siebenlist K, Herskind C, Wenz F, Giordano FA.

Radiother Oncol. 2013 Oct;109(1):152-8. doi: 10.1016/j.radonc.2013.09.009. Epub 2013 Oct 4.

PMID:
24100152
7.

Potential toxicities of prophylactic cranial irradiation.

Giordano FA, Welzel G, Abo-Madyan Y, Wenz F.

Transl Lung Cancer Res. 2012 Dec;1(4):254-62. doi: 10.3978/j.issn.2218-6751.2012.10.03. Review.

8.

Clinical relevance of different dose calculation strategies for mediastinal IMRT in Hodgkin's disease.

Koeck J, Abo-Madyan Y, Eich HT, Stieler F, Fleckenstein J, Kriz J, Mueller RP, Wenz F, Lohr F.

Strahlenther Onkol. 2012 Aug;188(8):653-9. doi: 10.1007/s00066-012-0144-x. Epub 2012 Jun 29.

PMID:
22740169
9.

ABVD vs. radiotherapy in early stage Hodgkin's lymphoma: A critical look at the NCIC HD.6 trial.

Wenz F, Abo-Madyan Y, Welzel G, Giordano FA.

Strahlenther Onkol. 2012 Aug;188(8):649-52. doi: 10.1007/s00066-012-0151-y. No abstract available.

PMID:
22729282
10.

Comparison of anisotropic aperture based intensity modulated radiotherapy with 3D-conformal radiotherapy for the treatment of large lung tumors.

Simeonova A, Abo-Madyan Y, El-Haddad M, Welzel G, Polednik M, Boggula R, Wenz F, Lohr F.

Radiother Oncol. 2012 Feb;102(2):268-73. doi: 10.1016/j.radonc.2011.10.006. Epub 2011 Nov 17.

PMID:
22100654
11.

Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.

Koeck J, Abo-Madyan Y, Lohr F, Stieler F, Kriz J, Mueller RP, Wenz F, Eich HT.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):268-76. doi: 10.1016/j.ijrobp.2011.05.054. Epub 2011 Nov 11.

PMID:
22079733
12.

Bone marrow-sparing intensity-modulated radiotherapy (IMRT) for neo-adjuvant therapy of inoperable cervical cancer in a patient with severe thrombocytopenia.

Simeonova A, Abo-Madyan Y, Ströbel P, Kleine W, Schwarzbach M, Fleckenstein K, Wenz F.

Onkologie. 2010;33(4):189-92. doi: 10.1159/000286279. Epub 2010 Mar 19.

PMID:
20389146
13.

A new strategy for online adaptive prostate radiotherapy based on cone-beam CT.

Boggula R, Lorenz F, Abo-Madyan Y, Lohr F, Wolff D, Boda-Heggemann J, Hesser J, Wenz F, Wertz H.

Z Med Phys. 2009;19(4):264-76. doi: 10.1016/j.zemedi.2009.05.007. Epub 2009 Jun 21.

PMID:
19962084
14.

A fast radiotherapy paradigm for anal cancer with volumetric modulated arc therapy (VMAT).

Stieler F, Wolff D, Lohr F, Steil V, Abo-Madyan Y, Lorenz F, Wenz F, Mai S.

Radiat Oncol. 2009 Oct 25;4:48. doi: 10.1186/1748-717X-4-48.

15.

Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer.

Wolff D, Stieler F, Welzel G, Lorenz F, Abo-Madyan Y, Mai S, Herskind C, Polednik M, Steil V, Wenz F, Lohr F.

Radiother Oncol. 2009 Nov;93(2):226-33. doi: 10.1016/j.radonc.2009.08.011. Epub 2009 Sep 16.

PMID:
19765846
16.

[Serial tomotherapy vs. MLC-IMRT (multileaf collimator intensity modulated radiotherapy) for simultaneous boost treatment large intracerebral lesions].

Wolff D, Abo-Madyan Y, Dobler B, Lohr F, Mai S, Polednik M, Wenz F.

Z Med Phys. 2009;19(1):58-66. German.

PMID:
19459586
17.

Improving dose homogeneity in large breasts by IMRT: efficacy and dosimetric accuracy of different techniques.

Abo-Madyan Y, Polednik M, Rahn A, Schneider F, Dobler B, Wenz F, Lohr F.

Strahlenther Onkol. 2008 Feb;184(2):86-92. doi: 10.1007/s00066-008-1730-9.

PMID:
18259700
18.

Evaluation of calculation algorithms implemented in different commercial planning systems on an anthropomorphic breast phantom using film dosimetry.

Polednik M, Abo Madyan Y, Schneider F, Wolff D, Bannach B, Lambrecht U, Wallin A, Cwiekala M, Maurer K, Reif F, Lohr F, Wenz F; Breast Cancer Working Group (German Cancer Association).

Strahlenther Onkol. 2007 Dec;183(12):667-72.

PMID:
18040610
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk